Welcome to
Accesstra Health Institute

Your trusted partner in advancing healthcare innovation, improving patient access, and strengthening health systems

We collaborate with pharmaceutical, biotech, medtech, diagnostics, and digital health companies — as well as governments, payers, and NGOs — to help them advance healthcare innovation, improve access to care, and strengthen the systems in which they operate.

From clinical development and market access to health system reform, VBHC projects, and policy design, we combine deep local expertise with global standards to deliver measurable impact across Oman and the Gulf region.

Learn more
Our Mission

To accelerate innovation in pharmaceuticals and health technologies, improve patient outcomes, and strengthen healthcare systems by delivering evidence-based, sustainable solutions across products, programs, and policies.

Our Vision

We envision a healthier future where people in Oman and the Gulf benefit from timely access to innovative medicines, medical devices, diagnostics, digital health solutions, and healthcare programs — all supported by efficient healthcare systems and forward-looking policies.

About us

Accesstra Health Institute was founded with the mission of bridging innovation and access in healthcare.

Our multidisciplinary team includes experts in clinical research, health economics, regulatory affairs, market access, policy, digital health, and health system transformation. We serve pharmaceutical, biotech, medtech, diagnostics, and digital health companies — as well as payers, providers, governments, and NGOs — helping them deliver results that matter for patients and health systems.

</br>

Our Services

Clinical Research and Evidence Generation

We generate the data and insights that drive product development, approval, access, and system integration.

  • Clinical trials (Phase I–III)
  • Post-approval studies (Phase IV, RWE, registries, observational studies)
  • Systematic reviews and meta-analyses
  • Biostatistics, data management, advanced analytics
  • Patient-reported outcomes (PRO), quality of life research
  • Health economics and outcomes research (HEOR)
  • Comparative effectiveness, benefit-risk analysis
Regulatory Strategy and Market Access

We help clients navigate regulatory pathways and secure access for:

  • Pharmaceuticals
  • Medical devices
  • In vitro diagnostics
  • Digital health technologies

Our services include:

  1. Regulatory strategy, dossier preparation, submission
  2. Local adaptation of global registration files
  3. Fast-track, orphan, and early access pathways
  4. Health authority engagement and negotiation
  5. Pricing strategy, cost-effectiveness, budget impact modeling
  6. Reimbursement submissions and negotiation support
  7. Value-based healthcare (VBHC) contracting and outcome-based payment models
Market Research, Strategy, and Commercial Planning

We equip clients with the knowledge to make informed, impactful decisions.

  • Market research and feasibility studies
  • Competitive landscape and patient journey mapping
  • Provider, payer, patient insights
  • Commercialization and launch strategy
  • Value proposition development for products and solutions
Medical Affairs and Stakeholder Engagement

We help companies build scientific leadership, credibility, and trust.

  • KOL (Key Opinion Leader) identification and engagement
  • Advisory boards, expert panels, and scientific boards
  • Medical writing (protocols, publications, presentations)
  • Scientific communication strategy and materials
  • Medical affairs strategy and training
  • Internal and external education programs
Policy, Health System, and VBHC Project Support

We help clients and governments improve healthcare policy, financing, and delivery.

  • Evidence generation to inform clinical guidelines, reimbursement, and policy
  • Methodological support for national guideline development
  • White papers, policy briefs, and technical reports
  • Healthcare financing and payment reform
  • Public health program evaluation and optimization
  • Digital health evaluation, integration, and scale-up
  • VBHC project design, pilot development, and management with payers, providers, and governments
Special Focus: Pharmaceutical and Medtech Clients

For pharma, biotech, medtech, diagnostics, and digital health companies, we offer an integrated pathway:

Clinical development → Market research → Commercial strategy → Regulatory approval → Pricing, HEOR, market access → Policy engagement → VBHC project management → Education, training, and stakeholder support.

We also help our clients shape the broader healthcare environment — supporting guideline development, payment model design, public health programs, and national health priorities.

Education
and Capacity Building

Empowering healthcare through knowledge

At Accesstra Health Institute, we believe that education is the foundation of a resilient, innovative, and patient-centered healthcare system.

Continuous learning empowers all stakeholders — clinicians, healthcare managers, policymakers, payers, and regulators — to make informed, evidence-based decisions that improve patient outcomes and strengthen health systems.

In today’s rapidly evolving healthcare landscape, professionals need more than clinical expertise. They must also understand the economic, organizational, and technological dimensions of healthcare.

Our educational programs combine international best practices with the local realities of Oman and the Gulf region, helping participants bridge knowledge and practice, innovation and access.

We offer executive and professional education designed to build the capabilities of healthcare leaders, innovators, and policymakers.

Training Focus Areas

An introduction to economic principles and tools applied in healthcare.

Participants learn how health resources are allocated, how to evaluate efficiency and value, and how economic evidence informs clinical and policy decisions.
Covers cost analysis, demand and supply in healthcare, and economic evaluation fundamentals.

Integrating clinical, economic, ethical, and social evidence to evaluate health innovations and guide decisions on coverage, pricing, and adoption.

This module builds on economic principles to teach HTA frameworks, methodologies, and international best practices.

Study of the social, behavioral, environmental, and economic factors — including equity and social justice — that shape health outcomes.

Focus on how health disparities arise and how evidence-based policies can address inequality and promote fairness across populations.

Exploration of how health systems are organized, financed, and governed.

Comparative analysis of system efficiency, equity, and sustainability.

Shifting from volume-based care to value-based outcomes.

Designing VBHC models, defining metrics, and structuring performance-based reimbursement systems.

Mechanisms of resource mobilization, pooling, and allocation.

Insights into government, insurance-based, and mixed financing models.

Comparing payment mechanisms —

fee-for-service, bundled payments, capitation, outcome-based contracts, shared savings — and their impact on incentives and quality.

Applying cost-effectiveness,

cost-utility, and cost-benefit analyses to inform healthcare decision-making, technology adoption,
and reimbursement.

Measuring patient quality of life, satisfaction, and functional outcomes.

Using PRO tools to inform research, VBHC initiatives, and HTA.

Harnessing telemedicine,

data analytics, and digital solutions to improve accessibility, efficiency, and patient engagement.

Applying AI and machine learning in diagnosis,

prediction, personalized medicine, and health system optimization.

Exploring the scientific,

ethical, and economic dimensions of next-generation therapies — and strategies for patient access and reimbursement.

Understanding the unique regulatory, clinical, and economic challenges of orphan drugs and rare disease management.

Exploring strategies for access, pricing, and sustainable reimbursement.

Approaches to improving outcomes across entire populations through prevention, early detection, and coordinated care.

Focus on data-driven insights, predictive modeling, and integrated delivery models.

Applying lean and continuous improvement principles to healthcare delivery.

Optimizing workflows, reducing waste, and improving quality and patient experience through data and design.

Global Expertise
and Collaboration

Our educational programs are developed and delivered in collaboration with leading international experts, universities, and healthcare organizations.

Together, we ensure that every learning experience reflects the latest global evidence, practical insights, and forward-looking solutions — empowering healthcare professionals to shape the future of healthcare in Oman, the Gulf, and beyond.

Why Choose Accesstra Health Institute

Comprehensive expertise:

Pharmaceuticals, medical devices, diagnostics, digital health, healthcare programs, and policy

Deep local knowledge:

Oman and Gulf regulatory, market access, and health system environments

Led by respected experts:

Including former health ministers, global HTA advisors, and senior clinical researchers

Full-spectrum solutions:

Product-centered and system-level impact

Commitment to ethics,

scientific rigor, and sustainable healthcare advancement

Global-quality standards:

Combined with practical local execution

Contact Us

Accesstra Health Institute

Dubai, UAE
Building A1, Dubai Digital Park, Dubai Silicon Oasis

Muscat, Sultanate of Oman
Office 109, Building 273, Block 308, North AI Mawaleh, Seeb

Let's shape the future of healthcare together.